Loading clinical trials...
Loading clinical trials...
This study evaluates treatment with combination versus monotherapy for patients with metastatic ocular melanoma.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Charite University, Berlin, Germany
NCT06007690 · Choroidal Melanoma, Indeterminate Lesions, and more
NCT07136181 · Metastatic Uveal Melanoma, Uveal Melanoma, Metastatic, and more
NCT05502900 · Uveal Melanoma, Uveal Melanoma, Posterior, Medium/Large Size, and more
NCT03172299 · Ocular Melanoma
NCT04417530 · Uveal Melanoma, Ocular Melanoma, and more
Hematology & Oncology Charité CBF Berlin
Berlin, State of Berlin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions